Zacks Research Upgrades Doximity (NYSE:DOCS) to Strong-Buy

Doximity (NYSE:DOCS) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports.

DOCS has been the subject of a number of other reports. The Goldman Sachs Group raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research report on Friday, January 9th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Barclays raised shares of Doximity to a “strong-buy” rating in a report on Monday, December 8th. Wall Street Zen lowered shares of Doximity from a “buy” rating to a “hold” rating in a report on Saturday, January 10th. Finally, Wells Fargo & Company upgraded Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price objective for the company in a research note on Tuesday, January 20th. Three equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $55.00.

Doximity Stock Performance

Shares of DOCS stock traded down $0.20 during mid-day trading on Monday, reaching $38.76. The stock had a trading volume of 484,196 shares, compared to its average volume of 2,533,501. Doximity has a 1-year low of $38.61 and a 1-year high of $85.21. The firm has a market capitalization of $7.30 billion, a PE ratio of 30.76, a P/E/G ratio of 1.87 and a beta of 1.39.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.